List of insiders holdings for Pacira BioSciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GORDON CARL L Director | 2011-02-10 18:47:36 | 0 2,828,941 | 2,828,941 | Form 4 |
| KAILIAN VAUGHN M GADICKE ANSBERT Former 10% Owner | 2013-03-13 12:32:23 | 0 2,790,479 | 2,790,479 | Form 4 |
| HBM Healthcare Investments (Cayman) Ltd. 10% Owner | 2014-03-17 17:50:00 | 1,667,307 0 | 1,667,307 | Form 13D |
| ORBIMED ADVISORS LLC OrbiMed Capital GP III LLC ISALY SAMUEL D 10% Owner | 2012-09-28 17:25:59 | 1,620,000 0 | 1,620,000 | Form 13D |
| Sanderling Venture Partners VI LP Sanderling VI Beteiligungs GmbH & Co KG Sanderling Ventures Management VI Sanderling VI Limited Partnership SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP MIDDLETON FRED A 10% Owner | 2013-04-15 20:09:24 | 1,582,192 0 | 1,582,192 | Form 4/A |
| MPM BioVentures IV QP LP MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG DOMBKOWSKI ASHLEY L Vander Vort John Scopa James Paul St Peter Steven Greene William 10% Owner | 2013-03-21 16:20:40 | 1,420,406 0 | 1,420,406 | Form 13D |
| MPM BioVentures IV QP LP MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG Foley Todd Vander Vort John Scopa James Paul St Peter Steven 10% Owner | 2013-03-21 16:20:40 | 1,420,406 0 | 1,420,406 | Form 13D |
| MPM BioVentures IV QP LP Scopa James Paul MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG Foley Todd Vander Vort John Former 10% Owner | 2013-03-21 16:20:40 | 1,420,406 0 | 1,420,406 | Form 13D |
| EVNIN LUKE Director | 2013-06-13 15:52:10 | 7000 824,255 | 831,255 | Form 4 |
| Lee Frank D. Chief Executive Officer | 2024-01-04 17:21:34 | 792,032 0 | 792,032 | Form 4 |
| Sanderling Venture Partners VI LP Sanderling VI Beteiligungs GmbH & Co KG Sanderling VI Limited Partnership Sanderling Venture Partners VI Co Investment Fund LP MIDDLETON FRED A 10% Owner | 2013-04-15 20:10:26 | 602,286 0 | 602,286 | Form 4/A |
| STACK DAVID M CEO and Chairman | 2023-06-16 17:40:44 | 431,881 116,184 | 548,065 | Form 4 |
| Wicki Andreas Director | 2021-03-16 21:12:35 | 0 451,324 | 451,324 | Form 4 |
| Pratt John General Manager, San Diego | 2013-06-14 18:29:44 | 261,982 0 | 261,982 | Form 4 |
| PATOU GARY Chief Medical Officer | 2014-08-08 16:31:55 | 80,453 702 | 81,155 | Form 4 |
| MIDDLETON FRED A Director | 2013-06-25 21:03:07 | 70,399 0 | 70,399 | Form 4 |
| Walters Mark SVP, Technicnical Operations | 2011-02-02 17:56:16 | 69,487 0 | 69,487 | Form 3 |
| Lambert William SVP, Pharmaceutical Dev | 2011-02-02 17:58:05 | 69,487 0 | 69,487 | Form 3 |
| GAUGLER DARYL Chief Operating Officer | 2024-02-07 16:59:39 | 65,494 0 | 65,494 | Form 4 |
| Reinhart Charles A. III Chief Financial Officer | 2023-06-16 17:38:03 | 65,126 0 | 65,126 | Form 4 |
| SLONIN JONATHAN Chief Medical Officer | 2024-01-04 17:24:39 | 61,196 0 | 61,196 | Form 4 |
| Braunstein Scott Chief Operating Officer | 2018-01-05 19:47:10 | 60,000 0 | 60,000 | Form 4 |
| WILLIAMS KRISTEN Chief Administrative Officer | 2024-02-07 16:59:53 | 59,075 0 | 59,075 | Form 4 |
| WINSTON ROY Chief Medical Officer | 2023-08-04 16:47:52 | 52,440 0 | 52,440 | Form 4 |
| LARANJEIRA CHARLES ANTHONY Chief Technical Officer | 2022-06-16 16:05:51 | 50,752 0 | 50,752 | Form 4 |
| Manning Donald C. Chief Medical Officer | 2021-06-11 20:35:45 | 44,520 0 | 44,520 | Form 4 |
| McLoughlin Dennis Chief Customer Officer | 2023-06-07 21:24:37 | 38,115 0 | 38,115 | Form 4 |
| Scranton Richard Chief Scientific Officer | 2019-11-12 17:10:00 | 36,311 0 | 36,311 | Form 4 |
| Kronenfeld Mark A. Director | 2023-06-16 17:34:16 | 32,597 0 | 32,597 | Form 4 |
| Young Alethia Director | 2023-10-11 16:47:07 | 30,967 0 | 30,967 | Form 4 |
| YANG MICHAEL J. Director | 2023-10-11 16:46:54 | 30,967 0 | 30,967 | Form 4 |
| BIGAL MARCELO Director | 2023-10-11 16:46:41 | 30,967 0 | 30,967 | Form 4 |
| Ceesay Abraham Director | 2023-10-11 16:46:28 | 30,967 0 | 30,967 | Form 4 |
| Ellis Ronald J. Jr. Chief Strategy Officer | 2023-06-07 21:20:41 | 30,909 0 | 30,909 | Form 4 |
| REINHARDT MAX President, Rest of World | 2023-06-07 21:28:17 | 29,225 0 | 29,225 | Form 4 |
| Scibetta James S President | 2017-06-07 19:00:29 | 25,118 0 | 25,118 | Form 4 |
| Brege Laura Director | 2023-06-16 17:26:07 | 24,247 0 | 24,247 | Form 4 |
| RIKER LAUREN Senior Vice President, Finance | 2024-01-04 17:25:59 | 22,528 0 | 22,528 | Form 4 |
| PACE GARY W Director | 2024-03-08 17:33:51 | 22,127 0 | 22,127 | Form 4 |
| Greenstreet Yvonne Director | 2022-06-08 19:26:28 | 21,472 0 | 21,472 | Form 4 |
| HASTINGS PAUL J Director | 2023-06-16 17:32:58 | 21,299 0 | 21,299 | Form 4 |
| Froimson Mark Director | 2023-06-16 17:30:17 | 20,768 0 | 20,768 | Form 4 |
| LONGENECKER JOHN P PHD Director | 2022-03-07 20:03:47 | 18,823 0 | 18,823 | Form 4 |
| CHRISTIE CHRISTOPHER Director | 2023-06-16 17:28:58 | 18,186 0 | 18,186 | Form 4 |
| Jones James B SVP & Chief Medical Officer | 2017-11-20 18:43:53 | 16,823 0 | 16,823 | Form 4 |
| MOLLOY ANTHONY Chief Lgl & Compliance Officer | 2023-06-07 21:26:59 | 12,877 0 | 12,877 | Form 4 |
| WINGER DENNIS L Director | 2017-06-16 20:18:24 | 10,204 0 | 10,204 | Form 4 |
| Markvicka Taunia SVP, Chief Commercial Officer | 2015-03-19 18:59:55 | 8579 230 | 8809 | Form 4 |
| Weiland Robert J. Chief Commercial Officer | 2018-06-06 20:11:05 | 5088 0 | 5088 | Form 4 |